|
⚲
|
| Keyboard |
| David Schenkein | |
|---|---|
| Firm | |
| Address | c/o Treeline Biosciences, Inc 500 Arsenal Street Watertown, MA 02472 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Treeline Biosciences Inc | 021-556563 | Director | 200.1 M of 250.0 M |
||
| Treeline Biosciences Inc | 021-527039 | Director | 421.8 M of 421.8 M |
||
| Denali Therapeutics Inc | 021-506551 | Director | 499.7 M of 499.7 M |
||
| Treeline Biosciences Inc | 021-461357 | Director | 261.3 M of 269.3 M |
||
| Treeline Biosciences Inc | 021-397744 | Director | 211.7 M of 220.0 M |
||
| Blueprint Medicines Corp | 021-228724 | Director | 50.0 M of 50.0 M |
||
| Blueprint Medicines Corp | 021-210375 | Director | 23.2 M of 25.1 M |
||
| Foundation Medicine Inc | 021-184482 | Director | 56.0 M of 56.0 M |
||
| Agios Pharmaceuticals Inc | 021-169115 | Executive Officer | 78.0 M of 78.0 M |
||
| Foundation Medicine Inc | 021-164823 | Director | 10.0 M of 20.5 M |
||
| Agios Pharmaceuticals Inc | 021-141089 | Executive Officer | 8.8 M of 8.8 M |
||